Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732 - Concepedia

Concepedia

Publication | Closed Access

Randomized Phase III Intergroup Trial of Etoposide and Cisplatin With or Without Paclitaxel and Granulocyte Colony-Stimulating Factor in Patients With Extensive-Stage Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 9732

187

Citations

22

References

2005

Year

Harvey B. Niell, James E. Herndon, Antonius A. Miller, Dorothy Watson, Alan B. Sandler, Karen Kelly, Randolph S. Marks, Micheal C. Perry, Rafat Ansari, G A Otterson,

Journal of Clinical Oncology

Abstract

PET did not improve the time to progression or survival in patients with extensive SCLC compared with EP alone and was associated with unacceptable toxicity.

References

	Year	Citations

Page 1